Core Viewpoint - The company believes that the current share price does not reflect its intrinsic value and actual business prospects, indicating strong confidence in long-term value [1] Share Buyback Details - The company repurchased 80,000 shares on November 28, 2025, for a total consideration of approximately HKD 2.0074 million, with an average price of about HKD 25.09 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 695,000 shares for approximately HKD 20.6924 million [1] Management's Perspective - The board of directors believes that the share buyback reflects management's confidence in the company's long-term value and is beneficial for enhancing market value and shareholder return capabilities [1] - The buyback is considered to be in the overall interest of the company and its shareholders [1]

Core Viewpoint - Meili Tianyuan Healthcare (02373) has repurchased shares, indicating management's confidence in the company's long-term value and business prospects [1] Summary by Sections Share Repurchase Details - The company repurchased 80,000 shares on November 28, 2025, for approximately HKD 2.0074 million, at an average price of HKD 25.09 per share [1] - From October 15, 2025, to the date of the announcement, the total shares repurchased amounted to 695,000, with a total cost of approximately HKD 20.6924 million [1] Management's Perspective - The board believes that the current share price does not reflect the intrinsic value of the shares and the actual business outlook of the company [1] - The share repurchase is seen as a demonstration of management's strong confidence in the company's long-term value, which is expected to enhance the group's market value and shareholder return capabilities [1] - The board asserts that the repurchase aligns with the overall interests of the company and its shareholders [1]

11月28日，贵州茅台公告称，选举陈华为公司第四届董事会董事长，并调整董事会专门委员会成员。 同时，公司决定投资不超过1.22亿元用于实施茅台厂区10kV高压双电源供电系统改造项目。 此外，贵州茅台公告，公司将以自有资金通过集中竞价交易方式回购股份，用于注销并减少注册资本， 回购价格不超过1887.63元/股（含），回购金额不低于15亿元（含）且不超过30亿元（含），实施 期限为自公司股东大会审议通过回购方案之日起6个月内。按照公司回购股份的价格上限测算，预计本 次回购股份数量约为794647股—1589294股，约占公司已发行总股本的0.0635%—0.1269%。 编辑 ｜ 钉钉 ...

Core Viewpoint - The company Kunshan Changying Hard Material Technology Co., Ltd. (referred to as "Changying Hard Science") has submitted an IPO application to the Beijing Stock Exchange, following a previous unsuccessful application to the Shanghai Stock Exchange. The company has undergone significant changes in its shareholding structure and governance prior to this new application [2][3][8]. Group 1: IPO Application and History - Changying Hard Science's IPO application was accepted by the Beijing Stock Exchange on June 30, 2025, and the company received its first round of inquiry on July 28, 2025 [2]. - The company previously submitted an IPO application to the Shanghai Stock Exchange on March 1, 2023, but withdrew it in June 2024 after responding to inquiries [2][8]. - Before the current IPO application, the founders executed a buyback obligation to external investors, repurchasing shares at a price of 18.98 yuan per share [2][9]. Group 2: Shareholding and Governance Changes - The controlling shareholders, Huang Qijun and Chen Bi, have reduced their share lock-up period from 36 months to 12 months compared to their previous IPO application [3][15]. - Two other founders, Yang Tiefei and Dai Xinguang, have exited their positions in the board and management prior to the IPO, which the company claims is part of governance optimization [3][16]. - As of the signing date of the prospectus, Huang Qijun and Chen Bi control 68.55% of the company, while Yang Tiefei and Dai Xinguang hold 16.63% and 8% respectively [5][13]. Group 3: Financial Obligations and Agreements - The founders signed multiple agreements with external investors, including buyback rights, which allow investors to require the original shareholders to repurchase shares if certain conditions are not met [6][7]. - The total amount required for the buyback obligations, if triggered, could reach approximately 99.91 million yuan [15]. - The company has stated that the special rights of investors will automatically terminate upon the acceptance of the IPO application by the Beijing Stock Exchange [14].

Core Viewpoint - The company plans to repurchase shares using its own funds through centralized bidding, aimed at reducing registered capital and subsequently canceling the repurchased shares [1] Summary by Relevant Sections Share Repurchase Details - The repurchase price will not exceed 1,887.63 yuan per share [1] - The total repurchase amount will be no less than 1.5 billion yuan and no more than 3 billion yuan [1] - The implementation period for the repurchase is within six months from the date the shareholders' meeting approves the repurchase plan [1] Estimated Impact - Based on the maximum repurchase price, the estimated number of shares to be repurchased is approximately 794,647 to 1,589,294 shares [1] - This represents about 0.0635% to 0.1269% of the company's total issued share capital [1] - The actual number of shares repurchased and the corresponding percentage of total share capital will be confirmed upon completion of the repurchase plan or expiration of the repurchase period [1]

Group 1 - The company China Feihe (06186.HK) announced a share buyback on November 28, spending HKD 9.586 million to repurchase 2.3 million shares [1]

键邦股份（603285）(603285.SH)发布公告，公司拟1500万元至3000万元回购公司股份，回购价格不超 过38元/股，回购的股份将在未来适宜时机用于实施员工持股计划或者股权激励。 ...

格隆汇11月28日丨键邦股份(603285.SH)公布,基于对公司未来持续稳定发展的信心和对公司长期价值的 认可，为进一步健全公司长效激励机制，充分调动公司员工积极性，结合公司经营情况及财务状况等因 素，依据相关规定，公司计划使用自有资金，以集中竞价交易方式回购公司股份。回购股份金额：不低 于人民币1500.00万元(含)，不超过人民币3000.00万元(含)。回购股份价格：不超过人民币38.00元/股 (含)，该价格未超过公司董事会审议通过相关决议前30个交易日公司股票交易均价的150%。本次回购的 股份将用于股权激励或员工持股计划。 来源：格隆汇APP ...

人民财讯11月28日电，键邦股份（603285）11月28日公告，公司计划使用自有资金，不低于1500万元 (含)，不超过3000万元(含)，以集中竞价交易方式回购公司股份，本次回购的股份将用于股权激励或员 工持股计划。回购股份价格不超过38元/股(含)，该价格未超过公司董事会审议通过相关决议前30个交易 日公司股票交易均价的150%。 ...

键邦股份11月28日公告，公司计划使用自有资金，以集中竞价交易方式回购公司股份，回购金额不低于 1500万元（含），不超过3000万元（含）。回购的股份将在未来适宜时机用于实施员工持股计划或者股 权激励。 ...